Norgine invests £23m in expanding Welsh pharmaceuticals production

Leading European specialist pharmaceutical company Norgine is investing £23m expanding production of pharmaceuticals in Hengoed, South Wales.

(c) Christine Sandu/Unsplash

(c) Christine Sandu/Unsplash

Secretary of state for Wales Jo Stevens announced the expansion while visiting the firm on Thursday 5 March.

Stevens said: ‘We have a thriving life sciences sector in Wales, and this investment from Norgine is a vote of confidence in our Welsh workforce. I am delighted that UK Government funding is supporting the business to continue to grow and create new well-paid jobs.

‘Norgine is a brilliant example of an international business that is flourishing in Wales. With our new international programme we are going to build on successes like this to attract even more investment that will create opportunities all around Wales.'

The £23m investment will expand warehousing and production space to meet increasing demand, as well as creating 44 new jobs. It has been unlocked by the Life Sciences Innovative Manufacturing Fund (LSIMF), a cornerstone of the UK Government's commitment to strengthening the health sector and one of the six headline commitments within the Life Sciences Sector Plan.

NHS signs long-term partnerships to deliver next generation of hospitals

By Paul Day 31 July 2026

The NHS has signed a series of long-term partnerships with construction firms to deliver the next phase of the New Hospital Programme, marking a significant ...

Burnham's care package: promise or placebo?

By Emily Whitehouse 30 July 2026

Just over twenty-four hours ago Andy Burnham unveiled his strategy to fix the social care sector. Since then, industry experts have shared their opinions and...

DAC Beachcroft strengthens health and public law team

By Lee Peart 23 July 2026

Law firm DAC Beachcroft has strengthened its health and public law team with two senior appointments.


Popular articles by Lee Peart